European Medicines Agency to review Ebola therapiesExperimental Ebola treatments are to be reviewed by the European Medicines Agency as part of the international response to the disease outbreak in West Africa.…
Patients more likely to stick to using generic rather than brand-name statins, US study suggests The use of generic statins generally led to better health outcomes for patients than those using brand-name drugs, a study showed – because the lower cost of the generic version usually meant better adherence. …
Improved glycaemic control with fixed-ratio combination of insulin degludec and liraglutideA new trial shows that patients who took IDegLira (Xultophy) for 26 weeks experienced a significantly greater mean reduction in HbA1c than patients taking either insulin degludec or liraglutide.…
Experimental antifungal drug causes fewer side effects than voriconazole A new experimental anti-fungal treatment is no less effective than its predecessor, but exposes patients to fewer side effects, a study has found.…
Potential role for benralizumab in COPD patients with eosinophilia Benralizumab therapy led to a numerical, albeit not statistically significant, improvement in COPD exacerbations and lung function compared with placebo.…
BioCryst remains hopeful of FDA approval for its single-dose influenza drug despite mixed results An experimental single-dose influenza drug has demonstrated mixed results in treating adult patients with flu when administered within 48 hours of the onset of symptoms.…
Novel heart failure therapy shows “overwhelming benefit”, trial shows A novel treatment for heart failure could save the lives of 20% more patients than the current gold-standard therapy.…
Drug manufacturers must provide accurate shelf life limits Hospital pharmacists are calling on drug manufacturers to include more accurate shelf life limits on compounded parenteral products.…
Antibacterial hydrogel could influence development of medical implants Researchers have developed an antibacterial hydrogel that reduces bacterial biofilm formation.…
Scientists develop gold nanoparticles to deliver cisplatin University of Cambridge scientists have developed gold nanoparticles containing cisplatin as part of a twofold attack on glioblastoma.…